Showing results (71-80 of 251) with videos related to

Sort By:
Pageof 26
European Journal of Pharmacology|February 26, 2000
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesionsA Ekesbo, P E Andrén, L M Gunne, et al.
Acta Psychiatrica Scandinavica|February 1, 1978
Endorphins in human cerebrospinal fluid: clinical correlations to some psychotic statesL H Lindström, E Widerlöv, L M Gunne, et al.
European Journal of Pharmacology|May 21, 1982
The pharmacological assessment of a new, potent oxotremorine analogue in mice and ratsB Resul, T Lewander, B Ringdahl, et al.
Psychopharmacology|January 1, 1989
Effects of d-amphetamine and methylphenidate on hyperactivity produced by neonatal 6-hydroxydopamine treatmentJ Luthman, A Fredriksson, T Lewander, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Biochemical pharmacology of the atypical neuroleptic remoxiprideC Köhler, H Hall, O Magnusson, et al.
L'Encephale|September 1, 1988
Neurobiochemical changes in tardive dyskinesiaL M Gunne, J E Häggström, P Johansson, et al.
Biochimica Et Biophysica Acta|October 1, 1991
On the mechanism of stimulation of cholesterol 7 alpha-hydroxylase by dietary cholesterolI Björkhem, G Eggertsen, U Andersson
The Biochemical Journal|April 15, 1997
ATP synthase subunit c expression: physiological regulation of the P1 and P2 genesU Andersson, J Houstek, B Cannon
Neuroreport|April 19, 1995
Neuroleptics differentially modulate central dopamine D1-receptor bindingA E Johnson, H Coirini, L Källström, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1992
Regional changes in 2-deoxyglucose uptake associated with neuroleptic-induced tardive dyskinesia in the Cebus monkeyI J Mitchell, A R Crossman, U Liminga, et al.
Pageof 26